Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Delle Monache S et al. | 2013 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC) and mouse pancreatic endothelial cell line (MS-1) | magnetic field, low frequency, 50/60 Hz | 1–2 mT |
| Denaro V et al. | 2011 | intact cell/cell culture | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.4 mT |
| Destefanis M et al. | 2015 | intact cell/cell culture, SKBR3 (human breast cancer cells), GTL16 (human gastric cancer cells), HT29 (human colon cancer cells), A375P (human melanoma cells) | magnetic field, 50/60 Hz | 12 µT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
| Dong Y et al. | 2021 | intact cell/cell culture | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Elexpuru-Zabaleta M et al. | 2023 | intact cell/cell culture, MDA-MB-231 and MCF-7 (breast cancer cell lines) and MCF-10A (breast cell line) | magnetic field, 50/60 Hz | - |
| Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
| Escobar JF et al. | 2020 | - | magnetic field, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
